Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Zai Lab Ltd

(NASDAQ: ZLAB)
Add to Portfolio
-3.51 (-5.59%)
as of 15:27 EST

Last 59.30
Change -3.51 (-5.59%)
Open 63.18
Prev. Close 62.81
Today's Range
58.77
63.30
52wk Range
23.42
63.95
Volume 244,050
Avg Volume 466,907
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
ZLAB -5.59% +40.53% +109.75%
DJIA -0.93% +3.76% +12.02%
S&P 500 -1.22% +6.30% +20.13%

Key Statistics

Annual EPS N/A
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 3,654,800
Weighted Alpha +113.40
Standard Deviation -2.22
Profit Margin N/A
Beta 1.34

Growth Rates

YTD +42.22%
1-Year +120.54%

Opinion

Sell Hold Buy

Recent Headlines

Zai Lab Announces Upcoming Participation at February

GlobeNewswire via COMTEX - Tue Feb 11, 07:30AM EST
Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB), a China and U.S.-based innovative commercial-stage biopharmaceutical company, today announced that Dr. Samantha Du, Founder and Chief Executive Officer, will be presenting at the followi(full story)
ZLAB: 59.30 (-3.51)

Zai Lab Announces Acceptance of NDA Submission of

GlobeNewswire via COMTEX - Mon Feb 10, 07:30AM EST
Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (ND(full story)
ZLAB: 59.30 (-3.51)

Zai Lab Announces First Patients Treated in Separate

GlobeNewswire via COMTEX - Tue Feb 04, 07:30AM EST
-- Registrational Bridging Study in China of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer(full story)
ZLAB: 59.30 (-3.51)

Zai Lab Announces Closing of Public Offering of

GlobeNewswire via COMTEX - Mon Jan 27, 04:30PM EST
Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the closing of its previously-announced underwritten public offering of 5,5(full story)
ZLAB: 59.30 (-3.51)

Zai Lab Announces Pricing of Public Offering of

GlobeNewswire via COMTEX - Wed Jan 22, 09:43PM EST
Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 5,500,000 American depos(full story)
ZLAB: 59.30 (-3.51)